Art

J-GLOBAL ID：201802232652824626   Reference number：18A1892745

Treatment of DIC associated with hematological malignancies

造血器悪性腫瘍に合併したDIC診療

Author (1)： SEKI YOSHINOBU (新潟大学医歯学総合病院魚沼地域医療教育センター 血液内科)
Material： 臨床血液  (Japanese Journal of Clinical Hematology)
Volume： 59  Issue： 10  Page： 2212-2221(J-STAGE)  Publication year： 2018 
JST Material Number： Z0688A  ISSN： 0485-1439  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human ,...
Semi thesaurus term： Recombinant Thrombomodulin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1892745&from=J-GLOBAL&jstjournalNo=Z0688A") }}

Author keywords (8)： DIC ,  Hematological malignancies ,  Diagnostic criteria ,  Therapeutic purpose ,  DIC ,  Hematological malignancies ,  Diagnostic criteria ,  Therapeutic purpose

JST classification (2)： Hematologic diseases  (GK03000F) ,  Clinical oncology in general  (GE03010Y)

Substance index (4)： 6-Aminocaproic acid ,  Tranexamic Acid ,  Gabexate mesylate ,  Nafamostat mesilate

Reference (50)：

• 1) Toh CH, Alhamdi Y. Current consideration and management of disseminated intravascular coagulation. Hematology Am Soc Hematol Educ Program. 2013; 2013: 286-291.
• 2) Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol. 2009; 69: 479-491.
• 3) Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013; 13: 34-45.
• 4) Müller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelet. FASEB J. 2003; 17: 476-478.
• 5) McDonald B, Pittman K, Menezes GB, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science. 2010; 330: 362-366.

Terms in the title (4)： 造血器悪性腫瘍 ,  合併 ,  DIC ,  診療